Technical Analysis for XFOR - X4 Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 7.4 -0.27% -0.02
XFOR closed down 0.27 percent on Monday, June 21, 2021, on 2.21 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical XFOR trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 200 DMA Bearish -0.27%
Volume Surge Other -0.27%
Below Lower BB Weakness -0.27%
Lower Bollinger Band Touch Weakness -0.27%
Oversold Stochastic Weakness -0.27%
Older End-of-Day Signals for XFOR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 7 hours ago
Rose Above Lower Bollinger Band about 11 hours ago
1.5x Volume Pace about 11 hours ago
Down 1% about 11 hours ago
Up 3% about 11 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

X4 Pharmaceuticals, Inc., formerly Arsanis, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare diseases including primary immunodeficiencies and cancer. The Company’s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance. Its product candidates include X4P-001, X4P-002 and X4P-003.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Rare Diseases Small Molecule Treatment Of Rare Diseases

Is XFOR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.7038
52 Week Low 5.38
Average Volume 154,469
200-Day Moving Average 7.86
50-Day Moving Average 8.50
20-Day Moving Average 8.76
10-Day Moving Average 8.37
Average True Range 0.58
ADX 20.84
+DI 17.10
-DI 24.11
Chandelier Exit (Long, 3 ATRs) 8.17
Chandelier Exit (Short, 3 ATRs) 8.99
Upper Bollinger Bands 10.10
Lower Bollinger Band 7.43
Percent B (%b) -0.01
BandWidth 30.50
MACD Line -0.20
MACD Signal Line 0.00
MACD Histogram -0.2002
Fundamentals Value
Market Cap 120.52 Million
Num Shares 16.3 Million
EPS -3.72
Price-to-Earnings (P/E) Ratio -1.99
Price-to-Sales 41.00
Price-to-Book 1.17
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.02
Resistance 3 (R3) 8.05 7.87 7.91
Resistance 2 (R2) 7.87 7.72 7.86 7.88
Resistance 1 (R1) 7.64 7.62 7.55 7.61 7.84
Pivot Point 7.46 7.46 7.42 7.45 7.46
Support 1 (S1) 7.23 7.31 7.14 7.20 6.96
Support 2 (S2) 7.05 7.21 7.04 6.92
Support 3 (S3) 6.82 7.05 6.89
Support 4 (S4) 6.79